Global Autoimmune Disease Diagnostics Market Trends and Outlook
Autoimmune diseases occur when the immune system mistakenly attacks healthy cells, causing inflammation, tissue damage, and organ dysfunction. They can be systemic, affecting multiple organs as in rheumatoid arthritis or lupus, or localized, targeting specific organs such as in type 1 diabetes or celiac disease. Diagnosing these conditions is complex due to overlapping symptoms, requiring a combination of clinical evaluation, patient history, and specialized laboratory testing. Common diagnostic tools include autoantibody detection assays like ANA and RF tests, organ-specific antibody analysis, inflammatory markers such as C-reactive protein and ESR, and imaging or biopsy studies for confirmation. Early and accurate diagnosis is essential for effective disease management and improved patient outcomes. Advances in genomics, proteomics, bioinformatics, and artificial intelligence are transforming the field, enabling more precise, personalized, and predictive diagnostic solutions that enhance clinical decision-making.
The global autoimmune disease diagnostics market is estimated at USD 6.2 billion in 2025 and projected to reach USD 10.2 billion by 2032, registering a CAGR of 7.5% during 2025 to 2032. Growth is driven by the rising prevalence of over 100 autoimmune disorders, including lupus, multiple sclerosis, and rheumatoid arthritis, alongside lifestyle and environmental factors that elevate risk. Growing awareness, government initiatives, and supportive reimbursement policies in developed economies are encouraging early testing. Rapid progress in immunoassays, biomarker research, molecular diagnostics, and next-generation sequencing has improved diagnostic speed and accuracy, while AI-enabled analytics enhance data interpretation. The expansion of point-of-care and at-home testing, supported by microfluidics-based platforms, is improving accessibility across regions. Strengthened healthcare infrastructure in Asia-Pacific, rising global health expenditure, and strategic collaborations between pharmaceutical and diagnostic firms are accelerating innovation. With aging populations, preventive healthcare trends, and the shift toward precision medicine, autoimmune disease diagnostics are becoming central to next-generation healthcare delivery.
Autoimmune Disease Diagnostics Regional Market Analysis
North America accounts for the largest share of the global autoimmune disease diagnostics market, estimated at 40.9% in 2025, supported by a high disease burden, advanced healthcare systems, favorable reimbursement policies, and strong presence of leading diagnostic companies. The United States anchors this leadership with extensive adoption of ELISA, chemiluminescence, and AI-based diagnostic platforms, complemented by robust R&D investments and broad insurance coverage. In contrast, Asia-Pacific is set to expand the fastest, recording a CAGR of 8.7% from 2025 to 2032, driven by rising prevalence of autoimmune conditions, improved healthcare access, and government-supported screening initiatives. China leads the region with its vast patient base and large-scale diagnostic programs, while India emerges as the fastest-growing market owing to expanding infrastructure, affordable test kits, and greater disease awareness. Japan continues to play a pivotal role in precision diagnostics, particularly for thyroid and celiac disorders, supported by national health programs and its aging population. The region's growth is reinforced by domestic manufacturing incentives, international partnerships, and increasing investments in healthcare innovation.
Autoimmune Disease Diagnostics Market Analysis by Product
Reagents & consumables represent the largest product category in the autoimmune disease diagnostics market, holding 67.2% of the share in 2025, owing to their recurring demand in high-volume laboratory testing and the increasing use of advanced assay kits for rapid, reliable results. Their continuous consumption in ELISA, immunofluorescence, and multiplex immunoassays, requiring specialized reagents, antibodies, and buffers, sustains this dominance. Expanding diagnostic networks, from hospitals to independent labs, further amplifies demand, while innovations in biomarkers and assay design drive the need for customized, high-precision reagents. Meanwhile, instruments, though smaller in share, are expected to post the fastest growth exceeding 8% CAGR during 2025-2032, driven by technological progress in lab automation, multiplex platforms, and AI-integrated systems enabling high-throughput, accurate, and rapid testing. The growing focus on early detection and automation supports steady instrument adoption, despite higher initial costs and longer replacement cycles.
Autoimmune Disease Diagnostics Market Analysis by Disease Type
Systemic autoimmune diseases lead the market in 2025 with a 63% share and are projected to grow at the fastest CAGR of 7.9% through 2032. Their dominance is attributed to the complexity of multi-organ conditions like rheumatoid arthritis, lupus, and multiple sclerosis that require comprehensive antibody panels and frequent monitoring. Rheumatoid arthritis holds the largest portion within this group at 36.4% in 2025, reflecting its widespread prevalence and the need for early biomarker-based detection through RF and anti-CCP assays. Multiple sclerosis, on the other hand, is emerging as the fastest-growing condition with a 9% CAGR, fueled by expanding biomarker research and the emphasis on early intervention to manage progression. Localized autoimmune diseases rank second in size, led by type 1 diabetes, and grows at 7.7% annually. Broader adoption of advanced molecular and immunoassay techniques, such as next-generation sequencing and improved ELISA platforms, is driving growth across conditions like inflammatory bowel disease and thyroid disorders. The focus on early diagnosis, lifelong disease management, and personalized therapeutic strategies is further propelling demand in this segment.
Autoimmune Disease Diagnostics Market Analysis by Test Type
Among test types, Antinuclear Antibody (ANA) tests hold the leading share of 30.9% in 2025, reflecting their central role in early detection and ongoing monitoring of autoimmune conditions. Their extensive use in hospitals and diagnostic laboratories is reinforced by continuous improvements in ELISA, indirect immunofluorescence, and multiplex assay technologies that enhance accuracy and throughput. Growing disease awareness, expansion of diagnostic facilities, and rising healthcare investment further sustain this segment's strong position. Meanwhile, Autoantibodies & Immunologic Tests are set to record the fastest growth, at 8.3% CAGR between 2025 and 2032, driven by their precision in detecting early-stage autoantibodies, the adoption of multiplexed and AI-assisted platforms, and increasing use in personalized medicine. The need for accurate, rapid, and cost-effective diagnostic solutions continues to fuel robust growth across both ANA and autoantibody testing segments worldwide.
Autoimmune Disease Diagnostics Market Report Scope
This global report on Autoimmune Disease Diagnostics analyzes the market based on product, disease type, and test type. In addition to providing profiles of major companies operating in this space, the latest corporate and industrial developments have been covered to offer a clear panorama of how and where the market is progressing.
Key Metrics
| Historical Period: | 2022-2024 | |
| Base Year: | 2025 | |
| Forecast Period: | 2025-2032 | |
| Units: | Value market in US$ | |
| Companies Mentioned: | 15+ |
Autoimmune Disease Diagnostics Market by Geographic Region
- North America (The United States, Canada, and Mexico)
- Europe (Germany, France, the United Kingdom, Italy, Spain, and Rest of Europe)
- Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, and Rest of South America)
- Rest of World
Autoimmune Disease Diagnostics Market by Product
- Reagents & Consumables
- Instruments
Autoimmune Disease Diagnostics Market by Disease Type
- Systemic Autoimmune Diseases
- Rheumatoid Arthritis (RA)
- Multiple Sclerosis (MS)
- Systemic Lupus Erythematosus (SLE)
- Psoriasis
- Other Systemic Autoimmune Diseases (Including Scleroderma, Sjogren's Syndrome, Dermatomyositis, Mixed Connective Tissue Disease, Behcet's Syndrome, Sarcoidosis, Myasthenia Gravis, and others)
- Localized Autoimmune Diseases
- Type 1 Diabetes
- Inflammatory Bowel Disease (IBD)
- Thyroid Disorders
- Other Localized Autoimmune Diseases (Including Idiopathic Thrombocytopenic Purpura (ITP), Celiac Disease, Addison's Disease, Guillain-Barre Syndrome, Autoimmune Hepatitis, Primary Biliary Cirrhosis, and others)
Autoimmune Disease Diagnostics Market by Test Type
- Antinuclear Antibody (ANA) Tests
- Autoantibodies and Immunologic Tests
- Complete Blood Count (CBC)?
- C-reactive Protein (CRP) Test
- Urinalysis
- Other Tests (Including Molecular Diagnostics, Inflammatory Markers, Point-of-care tests, Imaging diagnostics, and Emerging Tests)
Autoimmune Disease Diagnostics Market Frequently Asked Questions (FAQs)
The global autoimmune disease diagnostics market is projected to expand at a CAGR of 7.5% over the forecast period 2025-2032.
North America is the largest region in the global Autoimmune Disease Diagnostics market, holding a 40.9% share in 2025
Asia-Pacific is the fastest-growing region in the global Autoimmune Disease Diagnostics market, with a CAGR of 8.7% from 2025 to 2032.
Systemic autoimmune diseases are the leading disease type in the Autoimmune Disease Diagnostics market, accounting for 62.9% share in 2025.
Antinuclear Antibody (ANA) tests represent the largest test type market for Autoimmune Disease Diagnostics, capturing a 30.9% share in 2025.
The Autoimmune Disease Diagnostics market is driven by rising prevalence of autoimmune disorders, growing awareness, technological advancements in testing, expanding healthcare infrastructure, favorable reimbursement policies, and increasing adoption of personalized medicine.
The global market size for Autoimmune Disease Diagnostics is estimated at US$6.2 billion in 2025 and US$10.2 billion by 2032.
PART A: GLOBAL MARKET PERSPECTIVE
1. INTRODUCTION
- Product Outline
- Autoimmune Disease Diagnostics Defined
- Autoimmune Disease Diagnostics by Product
- Reagents & Consumables
- Instruments
- Autoimmune Disease Diagnostics by Disease Type
- Systemic Autoimmune Diseases
- Rheumatoid Arthritis (RA)
- Multiple Sclerosis (MS)
- Systemic Lupus Erythematosus (SLE)
- Psoriasis
- Other Systemic Autoimmune Diseases (Including Scleroderma, Sjogren's Syndrome, Dermatomyositis, Mixed Connective Tissue Disease, Behcet's Syndrome, Sarcoidosis, Myasthenia Gravis, and others)
- Localized Autoimmune Diseases
- Type 1 Diabetes
- Inflammatory Bowel Disease (IBD)
- Thyroid Disorders
- Other Localized Autoimmune Diseases (Including Idiopathic Thrombocytopenic Purpura (ITP), Celiac Disease, Addisons Disease, Guillain-Barre Syndrome, Autoimmune Hepatitis, Primary Biliary Cirrhosis, and others)
- Autoimmune Disease Diagnostics by Test Type
- Antinuclear Antibody (ANA) Tests
- Autoantibodies and Immunologic Tests
- Complete Blood Count (CBC)?
- C-reactive Protein (CRP) Test
- Urinalysis
- Other Tests (Including Molecular Diagnostics, Inflammatory Markers, Point-of-care tests, Imaging diagnostics, and Emerging Tests)
2. Key Market Trends
3. Key Global Players
- Abbott Laboratories
- AESKU.GROUP GmbH
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation (Beckman Coulter, Inc.)
- F. Hoffmann-La Roche Ltd
- Grifols, S.A.
- Hemagen Diagnostics, Inc.
- Labcorp Holdings Inc.
- Quest Diagnostics Incorporated
- Revvity, Inc. (EUROIMMUN)
- Siemens Healthineers AG
- Thermo Fisher Scientific, Inc.
- Trinity Biotech plc.
- Werfen, S.A.
4. Key Business & Product Trends
5. Global Market Overview
- Global Autoimmune Disease Diagnostics Market Overview by Product
- Autoimmune Disease Diagnostics Product Market Overview by Global Region
- Reagents & Consumables
- Instruments
- Global Autoimmune Disease Diagnostics Market Overview by Disease Type
- Autoimmune Disease Diagnostics Disease Type Market Overview by Global Region
- Systemic Autoimmune Diseases
- Rheumatoid Arthritis (RA)
- Multiple Sclerosis (MS)
- Systemic Lupus Erythematosus (SLE)
- Psoriasis
- Other Systemic Autoimmune Diseases
- Localized Autoimmune Diseases
- Type 1 Diabetes
- Inflammatory Bowel Disease (IBD)
- Thyroid Disorders
- Other Localized Autoimmune Diseases
- Global Autoimmune Disease Diagnostics Market Overview by Test Type
- Autoimmune Disease Diagnostics Test Type Market Overview by Global Region
- Antinuclear Antibody (ANA) Tests
- Autoantibodies and Immunologic Tests
- Complete Blood Count (CBC)?
- C-reactive Protein (CRP) Test
- Urinalysis
- Other Tests
PART B: REGIONAL MARKET PERSPECTIVE
- Global Autoimmune Disease Diagnostics Market Overview by Geographic Region
REGIONAL MARKET OVERVIEW
6. North America
- North American Autoimmune Disease Diagnostics Market Overview by Geographic Region
- North American Autoimmune Disease Diagnostics Market Overview by Product
- North American Autoimmune Disease Diagnostics Market Overview by Disease Type
- North American Autoimmune Disease Diagnostics Market Overview by Test Type
- Country-wise Analysis of the North American Autoimmune Disease Diagnostics Market
- The United States
- United States Autoimmune Disease Diagnostics Market Overview by Product
- United States Autoimmune Disease Diagnostics Market Overview by Disease Type
- United States Autoimmune Disease Diagnostics Market Overview by Test Type
- Canada
- Canadian Autoimmune Disease Diagnostics Market Overview by Product
- Canadian Autoimmune Disease Diagnostics Market Overview by Disease Type
- Canadian Autoimmune Disease Diagnostics Market Overview by Test Type
- Mexico
- Mexican Autoimmune Disease Diagnostics Market Overview by Product
- Mexican Autoimmune Disease Diagnostics Market Overview by Disease Type
- Mexican Autoimmune Disease Diagnostics Market Overview by Test Type
7. Europe
- European Autoimmune Disease Diagnostics Market Overview by Geographic Region
- European Autoimmune Disease Diagnostics Market Overview by Product
- European Autoimmune Disease Diagnostics Market Overview by Disease Type
- European Autoimmune Disease Diagnostics Market Overview by Test Type
- Country-wise Analysis of European Autoimmune Disease Diagnostics Market
- Germany
- German Autoimmune Disease Diagnostics Market Overview by Product
- German Autoimmune Disease Diagnostics Market Overview by Disease Type
- German Autoimmune Disease Diagnostics Market Overview by Test Type
- France
- French Autoimmune Disease Diagnostics Market Overview by Product
- French Autoimmune Disease Diagnostics Market Overview by Disease Type
- French Autoimmune Disease Diagnostics Market Overview by Test Type
- The United Kingdom
- United Kingdom Autoimmune Disease Diagnostics Market Overview by Product
- United Kingdom Autoimmune Disease Diagnostics Market Overview by Disease Type
- United Kingdom Autoimmune Disease Diagnostics Market Overview by Test Type
- Italy
- Italian Autoimmune Disease Diagnostics Market Overview by Product
- Italian Autoimmune Disease Diagnostics Market Overview by Disease Type
- Italian Autoimmune Disease Diagnostics Market Overview by Test Type
- Spain
- Spanish Autoimmune Disease Diagnostics Market Overview by Product
- Spanish Autoimmune Disease Diagnostics Market Overview by Disease Type
- Spanish Autoimmune Disease Diagnostics Market Overview by Test Type
- Rest of Europe
- Rest of Europe Autoimmune Disease Diagnostics Market Overview by Product
- Rest of Europe Autoimmune Disease Diagnostics Market Overview by Disease Type
- Rest of Europe Autoimmune Disease Diagnostics Market Overview by Test Type
8. Asia-Pacific
- Asia-Pacific Autoimmune Disease Diagnostics Market Overview by Geographic Region
- Asia-Pacific Autoimmune Disease Diagnostics Market Overview by Product
- Asia-Pacific Autoimmune Disease Diagnostics Market Overview by Disease Type
- Asia-Pacific Autoimmune Disease Diagnostics Market Overview by Test Type
- Country-wise Analysis of the Asia-Pacific Autoimmune Disease Diagnostics Market
- Japan
- Japanese Autoimmune Disease Diagnostics Market Overview by Product
- Japanese Autoimmune Disease Diagnostics Market Overview by Disease Type
- Japanese Autoimmune Disease Diagnostics Market Overview by Test Type
- China
- Chinese Autoimmune Disease Diagnostics Market Overview by Product
- Chinese Autoimmune Disease Diagnostics Market Overview by Disease Type
- Chinese Autoimmune Disease Diagnostics Market Overview by Test Type
- India
- Indian Autoimmune Disease Diagnostics Market Overview by Product
- Indian Autoimmune Disease Diagnostics Market Overview by Disease Type
- Indian Autoimmune Disease Diagnostics Market Overview by Test Type
- South Korea
- South Korean Autoimmune Disease Diagnostics Market Overview by Product
- South Korean Autoimmune Disease Diagnostics Market Overview by Disease Type
- South Korean Autoimmune Disease Diagnostics Market Overview by Test Type
- Rest of Asia-Pacific
- Rest of Asia-Pacific Autoimmune Disease Diagnostics Market Overview by Product
- Rest of Asia-Pacific Autoimmune Disease Diagnostics Market Overview by Disease Type
- Rest of Asia-Pacific Autoimmune Disease Diagnostics Market Overview by Test Type
9. South America
- South American Autoimmune Disease Diagnostics Market Overview by Geographic Region
- South American Autoimmune Disease Diagnostics Market Overview by Product
- South American Autoimmune Disease Diagnostics Market Overview by Disease Type
- South American Autoimmune Disease Diagnostics Market Overview by Test Type
- Country-wise Analysis of the South American Autoimmune Disease Diagnostics Market
- Brazil
- Brazilian Autoimmune Disease Diagnostics Market Overview by Product
- Brazilian Autoimmune Disease Diagnostics Market Overview by Disease Type
- Brazilian Autoimmune Disease Diagnostics Market Overview by Test Type
- Argentina
- Argentine Autoimmune Disease Diagnostics Market Overview by Product
- Argentine Autoimmune Disease Diagnostics Market Overview by Disease Type
- Argentine Autoimmune Disease Diagnostics Market Overview by Test Type
- Rest of South America
- Rest of South American Autoimmune Disease Diagnostics Market Overview by Product
- Rest of South American Autoimmune Disease Diagnostics Market Overview by Disease Type
- Rest of South American Autoimmune Disease Diagnostics Market Overview by Test Type
10. Rest of World
- Rest of World Autoimmune Disease Diagnostics Market Overview by Product
- Rest of World Autoimmune Disease Diagnostics Market Overview by Disease Type
- Rest of World Autoimmune Disease Diagnostics Market Overview by Test Type
PART C: GUIDE TO THE INDUSTRY
PART D: ANNEXURE
1. RESEARCH METHODOLOGY
2. FEEDBACK
Abbott Laboratories
AESKU.GROUP GmbH
bioMerieux SA
Bio-Rad Laboratories, Inc.
Danaher Corporation (Beckman Coulter, Inc.)
F. Hoffmann-La Roche Ltd
Grifols, S.A.
Hemagen Diagnostics, Inc.
Labcorp Holdings Inc.
Quest Diagnostics Incorporated
Revvity, Inc. (EUROIMMUN)
Siemens Healthineers AG
Thermo Fisher Scientific, Inc.
Trinity Biotech plc.
Werfen, S.A.
Take Advantage of Year-end Discounts!
Click "Avail Offer", and email us to get the discount!
15% off
Offer ends Jan 15, 2026
RELATED REPORTS
Global Anatomic Pathology Market - Products and Applications
Report Code: CDG008 | Pages: 256 | Price: $4500
Published
Oct 2025
Anti-Nuclear Antibody (ANA) Testing - A Global Market Overview
Report Code: CDG004 | Pages: 313 | Price: $4500
Published
Sep 2025
Global Cancer Diagnostics Market - Technologies, Applications and End-Use Facilities
Report Code: CDG021 | Pages: 278 | Price: $4500
Published
Aug 2025
Global Cardiac Biomarkers Market - Types, Applications and Testing Locations
Report Code: CDG017 | Pages: 256 | Price: $4500
Published
Aug 2025
Global Direct-to-Consumer (DTC) Genetic Testing Market - Test Types, Technologies and Distribution Channels
Report Code: CDG027 | Pages: 262 | Price: $4500
Published
Aug 2025